NCT03292029View on ClinicalTrials.gov

Pilot Medical Evaluation of the T50 Test

NACompletedINTERVENTIONAL
Enrollment

776

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

October 5, 2019

Study Completion Date

March 4, 2020

Conditions
Renal FailureCardiovascular DiseasesVascular Calcification
Interventions
DIAGNOSTIC_TEST

T50 Calcification Inhibition Test (CIT)

Measurement of predialysis T50 CIT and fetuin-A values in serum of hemodialysis patients

Trial Locations (8)

43007

Centro de Diálisis Tarragona, Tarragona

43205

Centro de Diálisis Reus, Reus

08013

Centro de Diálisis Barcelona - Glories, Barcelona

08019

Centro de Diálisis Barcelona - Diagonal, Barcelona

08029

Centro de Diálisis Barcelona - Rosselló, Barcelona

08401

Centro de Diálisis Granollers, Granollers

08901

Centro de Diálisis Hospitalet, L'Hospitalet de Llobregat

08223

Centro de Diálisis Terrassa, Terrassa

All Listed Sponsors
lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT03292029 - Pilot Medical Evaluation of the T50 Test | Biotech Hunter | Biotech Hunter